Halozyme Therapeutics (HALO) EPS (2011 - 2026)
Halozyme Therapeutics (HALO) EPS from Mar 31, 2011 to Mar 31, 2026. The TTM Halozyme Therapeutics (HALO) EPS is $2.96. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Halozyme Therapeutics (HALO) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -23.85% |
| 3 Years TTM | +29.95% |
| 5 Years TTM | +20.06% |
Annual EPS change of Halozyme Therapeutics (HALO)
| Year | EPS | Change |
|---|---|---|
| 2026 | $1.27 | -52.95% |
| 2025 | $2.69 | -25.40% |
| 2024 | $3.61 | +62.36% |
| 2023 | $2.22 | +48.52% |
| 2022 | $1.50 | -48.94% |
| 2021 | $2.93 | +206.36% |
| 2020 | $0.96 | -280.92% |
| 2019 | -$0.53 | -4.80% |
| 2018 | -$0.56 | -225.86% |
| 2017 | $0.44 | -155.44% |
| 2016 | -$0.80 | +216.31% |
| 2015 | -$0.25 | -53.75% |
| 2014 | -$0.54 | -25.39% |
| 2013 | -$0.73 | +53.41% |
| 2012 | -$0.48 | +149.91% |
| 2011 | -$0.19 | -64.08% |
| 2010 | -$0.53 | N/A |
Comparison Halozyme Therapeutics (HALO) five years EPS CAGR with competitors
Halozyme Therapeutics (HALO) five years EPS CAGR is 20.06%.